Amarin Corp Plcuk (AMRN) Short-term Investments (2020 - 2026)

Amarin Corp Plcuk (AMRN) reported Short-term Investments of $176.8 million for Q1 2026, up 8.96% year-over-year from $162.3 million in Q1 2025, and up 5.28% quarter-over-quarter from $167.9 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Short-term Investments (2020 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 7 years of Short-term Investments data on file, last reported at $176.8 million in Q1 2026.

  • Short-term Investments for Q1 2026 came in at $176.8 million, up 8.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $176.8 million (up 8.96% YoY), and the FY2025 annual result was $167.9 million, down 3.03% from the prior year.
  • Short-term Investments grew to $176.8 million in Q1 2026 per AMRN's latest filing, from $167.9 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $176.8 million in Q1 2026 and troughed at $49.8 million in Q3 2023.
  • A 5-year average of $122.1 million and a median of $121.4 million in 2023 frame the typical range for Short-term Investments.
  • The sharpest annual moves came in 2022 and 2024: Short-term Investments tumbled 75.34% in 2022, then soared 198.48% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $91.7 million in 2022, then surged by 32.4% to $121.4 million in 2023, then surged by 42.65% to $173.2 million in 2024, then decreased by 3.03% to $167.9 million in 2025, then climbed by 5.28% to $176.8 million in 2026.
  • Business Quant data shows AMRN's Short-term Investments at $176.8 million in Q1 2026, $167.9 million in Q4 2025, and $163.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 176.80 Mn
Dec 31, 2025 167.93 Mn
Sep 30, 2025 163.80 Mn
Jun 30, 2025 150.80 Mn
Mar 31, 2025 162.26 Mn
Dec 31, 2024 173.18 Mn
Sep 30, 2024 148.79 Mn
Jun 30, 2024 90.70 Mn
Mar 31, 2024 94.24 Mn
Dec 31, 2023 121.41 Mn
Sep 30, 2023 49.85 Mn
Jun 30, 2023 79.90 Mn
Mar 31, 2023 112.96 Mn
Dec 31, 2022 91.70 Mn
Sep 30, 2022 63.20 Mn
Jun 30, 2022 85.23 Mn
Mar 31, 2022 143.41 Mn
Dec 31, 2021 234.67 Mn
Sep 30, 2021 256.30 Mn
Jun 30, 2021 181.91 Mn